Amgen receives FDA approval for Kyprolis combination therapy to treat multiple myeloma
The US Food and Drug Administration (FDA) has granted approval for Amgens' Kyprolis (carfilzomib) combination therapy to treat patients with…
The US Food and Drug Administration (FDA) has granted approval for Amgens' Kyprolis (carfilzomib) combination therapy to treat patients with…
Around 85 international pharmaceutical, generics, diagnostics and biotechnology firms have urged governments and industry to take comprehensive action on drug-resistant…
Upsher-Smith Laboratories wholly-owned subsidiary Proximagen has partnered with biotech firm Saniona to develop novel therapeutics for neurological disorders.Under the drug…
Biopharmaceutical firm AbbVie has received breakthrough therapy status from the US Food and Drug Administration (FDA) for its venetoclax in…
Acorda Therapeutics has signed an agreement to acquire Finland-based biopharmaceutical firm Biotie Therapies for approximately $363m. Based in Turku, Biotie…
MediciNova has received rare paediatric disease status from the US Food and Drug Administration (FDA) for its MN-166 (ibudilast) to…
Wellstat Therrpeutics has received approval from the US Food and Drug Administration (FDA) for its Vistogard (uridine triacetate) to treat…
The Federal Court of Australia has ruled that UK-based Reckitt Benckiser's Nurofen made misleading pain relief claims.According to the Australian…
Switzerland-based biotech firm Omnio has teamed-up with Canadian pharmaceutical firm ProMetic to develop a new drug for slow-healing chronic wounds.…
Baxalta has received marketing approval from the European Commission for its Obizur (Antihaemophilic Factor [ecombinant], Porcine Sequence) to treat adult…